IP Library Assignment 073815/0912
Patent Assignment
Reel/Frame 073815/0912

Assignment of Security Interest in Patent Rights, Recorded on October 20, 2021, at Reel/Frame 057861/0905

Recorded: 2025-12-03 Pages: 15
Assignor
Assignee
JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
WLS – DOCUMENT WORKFLOW MANAGEMENT, 10 SOUTH DEARBORN STREET – FLOOR L2, MAIL CODE IL1-1190, CHICAGO, ILLINOIS, 60603
Covered Properties (47)
Methods of Using Metamizole for Treatment of Pyrexia in Equines
Application: 16/438,130 →
Publication: US 2019/0374509
Anti-IL31 Antibodies for Veterinary Use
Application: 62/463,543 →
Anti-IL31 Antibodies for Veterinary Use
Application: 17/039,495 →
Publication: US 2021/0163587
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 17/287,756 →
Publication: US 2021/0395340
Feline Erythropoietin and Its Derivatives for Veterinary Use
Application: 62/516,092 →
Erythropoietin and Its Derivatives for Veterinary Use
Application: 62/516,642 →
Erythropoietin and Analogs for Veterinary Use
Application: 62/559,104 →
Erythropoietin and Analogs for Veterinary Use
Application: 16/617,380 →
Publication: US 2021/0032305
Erythropoietin Analogs for Veterinary Use
Application: 62/778,849 →
Erythropoietin Analogs for Veterinary Use
Application: 62/779,332 →
Erythropoietin Analogs for Veterinary Use
Application: 62/785,691 →
Methods of using Metamizole for Treatment of Pyrexia in Equines
Application: 62/818,221 →
IgG Fc Variants for Veterinary Use
Application: 16/638,402 →
Publication: US 2020/0362034
Igg Fc Variants for Veterinary Use
Application: 62/545,858 →
Variant Asparaginase Polypeptides for Medical Use
Application: 62/660,189 →
Variant Asparaginase Polypeptides for Medical Use
Application: 17/048,355 →
Publication: US 2021/0062176
Anti-IL4 Receptor Antibodies for Veterinary Use
Application: 17/274,746 →
Publication: US 2022/0049002
Anti-IL4 Receptor Antibodies for Veterinary Use
Application: 62/731,633 →
IGG FC Variants for Veterinary Use
Application: 62/785,680 →
Anti-IL4 Receptor Antibodies for Veterinary Use
Application: 62/991,568 →
Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use
Application: 17/284,875 →
Publication: US 2021/0388053
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 62/488,509 →
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 62/750,782 →
Il4/IL13 Receptor Molecule for Veterinary Use
Application: 63/014,090 →
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 63/014,573 →
IL17A Antibodies and Antagonists for Veterinary Use
Application: 62/521,514 →
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 16/605,356 →
Publication: US 2020/0048325
IL17A Antibodies and Antagonists for Veterinary Use
Application: 16/621,012 →
Publication: US 2020/0199216
Anti-IL31 Antibodies for Veterinary Use
Application: 63/014,033 →
Anti-IL31 Antibodies for Veterinary Use
Application: 63/014,549 →
TNF Alpha Antibodies for Veterinary Use
Application: 63/127,994 →
TNF Alpha Antibodies for Veterinary Use
Application: 63/128,804 →
Methods of Treating a Companion Animal Species Comprising Administering Anti-IL31 Antibodies
Application: 16/488,045 →
Publication: US 2020/0062840
Anti-IL31 Antibodies for Veterinary Use
Application: 62/893,799 →
Anti-IL31 Antibodies for Veterinary Use
Application: 62/894,526 →
NGF Antagonists for Medical Use
Application: 62/821,438 →
Anti-Parvovirus Antibodies for Veterinary Use
Application: 62/880,650 →
Parvovirus Antibodies for Veterinary Use
Application: 62/968,970 →
Parvovirus Antibodies for Veterinary Use
Application: 63/030,123 →
Equine Esomeprazole Formulations and Methods of Use
Application: 62/874,702 →
Equine Esomeprazole Formulations and Methods of Use
Application: 63/038,549 →
Compositions and Methods for Treatment and Prevention of Pyrexia in Horses
Application: 16/869,018 →
Publication: US 2020/0330436
Methods for Treatment and Prevention of Pyrexia in Horses
Application: 62/127,401 →
Methods of Using Metamizole for Treatment of Pyrexia in Equines
Application: 62/683,882 →
Anti-IL31 Antibodies for Veterinary Use
Application: 15/467,464 →
Publication: US 2018/0244766
Compositions and Methods for Treatment and Prevention of Pyrexia in Horses
Application: 15/554,568 →
Publication: US 2018/0071256
Anti-IL31 Antibodies for Veterinary Use
Application: 15/844,142 →
Publication: US 2018/0244767
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 3, 2017
From: LI, SHYR JIANN; NGUYEN, LAM; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 041887/0463 →
Assignment of Assignor's Interest Jun 19, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; CHU, QINGYI
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 042750/0424 →
Assignment of Assignor's Interest Jun 27, 2017
From: LI, SHYR JIANN; NGUYEN, LAM; YANG, LAN; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 042829/0512 →
Assignment of Assignor's Interest Jul 19, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; CHU, QINGYI
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043040/0575 →
Assignment of Assignor's Interest Jul 19, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; QIAN, FAWN; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043040/0506 →
Assignment of Assignor's Interest Aug 24, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043389/0626 →
Assignment of Assignor's Interest Oct 25, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; CHU, QINGYI
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043947/0284 →
Assignment of Assignor's Interest May 21, 2018
From: ZHAN, HANGJUN; NGUYEN, LAM; CHIN, RICHARD; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 045857/0251 →
Assignment of Assignor's Interest Oct 16, 2018
From: LI, SHYR JIANN; NGUYEN, LAM; CHIN, RICHARD; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 047185/0292 →
Assignment of Assignor's Interest Nov 15, 2018
From: ZHAN, HANGJUN; NGUYEN, LAM; QIAN, FAWN; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 047516/0259 →
Assignment of Assignor's Interest Jan 15, 2019
From: ZHAN, HANGJUN; NGUYEN, LAM; CHU, QINGYI; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 048012/0300 →
Assignment of Assignor's Interest Jan 16, 2019
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 048025/0314 →
Assignment of Assignor's Interest Apr 3, 2019
From: SUNDMAN, EMILY; O'BANION, MELINDA POOLE
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 048778/0322 →
Assignment of Assignor's Interest Mar 18, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 052148/0714 →
Assignment of Assignor's Interest May 5, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; CHIN, RICHARD; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 052573/0178 →
Assignment of Assignor's Interest May 13, 2020
From: ZHAN, HANGJUN; NGUYEN, LAM; QIAN, FAWN; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 052648/0143 →
Assignment of Assignor's Interest May 22, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; CHU, QINGYI; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 052734/0155 →
Assignment of Assignor's Interest Jun 25, 2020
From: SUNDMAN, EMILY; O'BANION, MELINDA POOLE
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 053036/0489 →
Assignment of Assignor's Interest Jul 9, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; CHU, QINGYI; CHIN, RICHARD
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 053161/0530 →
Assignment of Assignor's Interest Sep 25, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; YANG, LAN; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 053881/0049 →
Assignment of Assignor's Interest Jan 14, 2021
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 054916/0619 →
Assignment of Assignor's Interest Jul 9, 2021
From: LI, SHYR JIANN; NGUYEN, LAM; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 056817/0448 →
Security Interest Oct 20, 2021
From: KINDRED BIOSCIENCES, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057861/0905 →
Partial Release of Security Interest Jul 22, 2022
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 060814/0350 →
Assignment of Assignor's Interest Oct 11, 2022
From: KINDRED BIOSCIENCES, INC.
To: DECHRA LIMITED
Reel/Frame 061375/0599 →